CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113516358
- Phone
- (984) 884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-21 | YERXA BENJAMIN R President | Purchase | +10,000 | $0.98 | $10K | 342,800 |
| 2024-11-18 | Magrath George Chief Executive Officer | Purchase | +9,706 | $1.02 | $10K | 492,950 |
| 2024-11-15 | Magrath George Chief Executive Officer | Purchase | +90,294 | $1.01 | $91K | 483,244 |
| 2024-11-07 | YERXA BENJAMIN R President | Grant or award | +332,800 | 332,800 | ||
| 2024-11-01 | Magrath George Chief Executive Officer | Shares withheld for taxes | −37,050 | $1.18 | $44K | 392,950 |
| 2024-10-22 | Graves Adrienne L Director | Grant or award · Stock Option (right to buy) | +172,874 | 172,874 | ||
| 2024-10-22 | Bennett Jean Director | Grant or award | +100,000 | 100,000 | ||
| 2024-10-22 | Bennett Jean Director | Grant or award · Stock Option (right to buy) | +172,874 | 172,874 | ||
| 2024-06-11 | Rodgers Richard J Director | Grant or award | +41,143 | 239,151 | ||
| 2024-06-11 | Rodgers Richard J Director | Grant or award · Stock Option (Right to Buy) | +35,181 | 35,181 | ||
| 2024-06-11 | Pepose Jay Director | Grant or award | +41,143 | 180,458 | ||
| 2024-06-11 | Pepose Jay Director | Grant or award · Stock Option (Right to Buy) | +35,181 | 35,181 | ||
| 2024-06-11 | MANUSO JAMES S J Director | Grant or award | +41,143 | 132,037 | ||
| 2024-06-11 | MANUSO JAMES S J Director | Grant or award · Stock Option (Right to Buy) | +35,181 | 35,181 | ||
| 2024-06-11 | Gallagher Cam Director | Grant or award | +41,143 | 77,047 | ||
| 2024-06-11 | Gallagher Cam Director | Grant or award · Stock Option (Right to Buy) | +35,181 | 35,181 | ||
| 2024-06-11 | Benton Susan Director | Grant or award | +41,143 | 140,023 | ||
| 2024-06-11 | Benton Susan Director | Grant or award · Stock Option (Right to Buy) | +35,181 | 35,181 | ||
| 2024-06-11 | Ainsworth Sean Director | Grant or award | +41,143 | 88,358 | ||
| 2024-06-11 | Ainsworth Sean Director | Grant or award · Stock Option (Right to Buy) | +35,181 | 35,181 |
Page 6 of 7 · 136 trades